|
Total
|
DS-MV˂ = 30 (n = 100)
|
DS-MV > 30 (n = 55)
|
p value
|
---|
Age
|
52.9 (45.4–59.2)
|
53.3 (44.8–59.8)
|
52.2 (47–59.2)
|
0.982
|
Gender
| | | |
0.455
|
Male
|
147 (94.8%)
|
96 (96.0%)
|
51 (92.7%)
| |
Female
|
8 (5.2%)
|
4 (4.0%)
|
4 (7.3%)
| |
Education
| | | |
0.627
|
Elementary school
|
16 (10.3%)
|
10 (10.0%)
|
6 (10.9%)
| |
Junior school
|
55 (35.5%)
|
35 (35.0%)
|
20 (36.4%)
| |
Senior high school
|
68 (43.9%)
|
47 (47.0%)
|
21 (38.2%)
| |
College
|
13 (8.4%)
|
6 (6.0%)
|
7 (12.7%)
| |
Research institute
|
3 (1.9%)
|
2 (2.0%)
|
1 (1.8%)
| |
Marital status
| | | |
0.743
|
Married
|
119 (76.8%)
|
79 (79.0%)
|
40 (72.7%)
| |
Never married
|
23 (14.8%)
|
14 (14.0%)
|
9 (16.4%)
| |
Divorced
|
10 (6.5%)
|
5 (5.0%)
|
5 (9.1%)
|
(9.1%)
|
Widowed
|
3 (1.9%)
|
2 (2.0%)
|
1 (1.8%)
| |
Religious affiliation
| | | |
0.261
|
Atheist
|
21 (13.5%)
|
14 (14.0%)
|
7 (12.7%)
| |
Taoism
|
83 (53.5%)
|
58 (58.0%)
|
25 (45.5%)
| |
Buddhism
|
40 (25.8%)
|
21 (21.0%)
|
19 (34.5%)
| |
Christianity
|
3 (1.9%)
|
1 (1.0%)
|
2 (3.6%)
| |
Other
|
8 (5.2%)
|
6 (6.0%)
|
2 (3.6%)
| |
Employment status
| | | |
0.394
|
Full-time job
|
104 (67.1%)
|
69 (69.0%)
|
35 (63.6%)
| |
Retired
|
22 (14.2%)
|
14 (14.0%)
|
8 (14.5%)
| |
Part-time job
|
17 (11.0%)
|
8 (8.0%)
|
9 (16.4%)
| |
Unemployment
|
9 (5.8%)
|
6 (6.0%)
|
3 (5.5%)
| |
Housewife/househusband
|
3 (1.9%)
|
3 (3.0%)
|
0 (0.0%)
| |
Monthly income(NTD)
| | | |
0.069
|
$20,000 or less
|
36 (23.2%)
|
21 (21.0%)
|
15 (27.3%)
| |
$20,001–$40,000
|
59 (38.1%)
|
39 (39.0%)
|
20 (36.4%)
| |
$40,001–$60,000
|
41 (26.5%)
|
23 (23.0%)
|
18 (32.7%)
| |
$60,001 or more
|
19 (12.3%)
|
17 (17.0%)
|
2 (3.6%)
| |
Tumor stage
| | | |
0.567
|
0
|
2 (1.3%)
|
2 (2.0%)
|
0 (0.0%)
| |
I
|
31 (20.0%)
|
20 (20.0%)
|
11 (20.0%)
| |
II
|
39 (25.2%)
|
23 (23.0%)
|
16 (29.1%)
| |
III
|
21 (13.5%)
|
16 (16.0%)
|
5 (9.1%)
| |
IV
|
62 (40.0%)
|
39 (39.0%)
|
23 (41.8%)
| |
Treatment
| | | |
0.303
|
Surgery
|
132 (85.2%)
|
88 (88.0%)
|
44 (80.0%)
| |
Chemotherapy
|
10 (6.5%)
|
6 (6.0%)
|
4 (7.3%)
| |
Symptom relief
|
12 (7.7%)
|
5 (5.0%)
|
7 (12.7%)
| |
Immunotherapy
|
1 (0.6%)
|
1 (1.0%)
|
0 (0.0%)
| |
Time since diagnosis
| | | |
0.185
|
1–2 years
|
11 (7.1%)
|
6 (6.0%)
|
5 (9.1%)
| |
< 3 months
|
83 (53.5%)
|
60 (60.0%)
|
23 (41.8%)
| |
3 months–1 year
|
17 (11.0%)
|
10 (10.0%)
|
7 (12.7%)
| |
> 2 years
|
44 (28.4%)
|
24 (24.0%)
|
20 (36.4%)
| |
Recurrence (Yes)
|
41 (26.5%)
|
22 (22.0%)
|
19 (34.5%)
|
0.133
|
Under anti-cancer treatment(Yes)
|
145 (100%)
|
96 (96.0%)
|
49 (89.1%)
|
0.168
|
Location
| | | |
0.083
|
Tongue
|
61 (39.4%)
|
37 (37.0%)
|
24 (43.6%)
| |
Buccal
|
44 (28.4%)
|
35 (35.0%)
|
9 (16.4%)
| |
Gum
|
26 (16.8%)
|
16 (16.0%)
|
10 (18.2%)
| |
Mouth
|
19 (12.3%)
|
11 (11.0%)
|
8 (14.5%)
| |
Lip
|
4 (2.6%)
|
1 (1.0%)
|
3 (5.5%)
| |
Oropharynx
|
1 (0.6%)
|
0 (0.0%)
|
1 (1.8%)
| |
Suicidal ideation(Yes)
|
18 (11.6%)
|
16 29.1%
|
2 2%
|
< 0.001*
|
Global health status/QoL
|
50.0 (33.3-66.7)
|
58.0 (41.8–75)
|
50.0 (17–58.3)
|
< 0.001*
|
Functional scales
|
69.0 (57-81)
|
77.2 (63.3–86.6)
|
59.4 (46.3–69.3)
|
< 0.001*
|
Physical functioning
|
73.3 (60-87)
|
80.0 (61.7–93)
|
67.0 (46.7–86.7)
|
0.015
|
Role functioning
|
66.7 (33.3-100)
|
66.7 (33.3–100)
|
50.0 (33–100)
|
0.048
|
Emotional functioning
|
75.0 (66.7-91.7)
|
83.3 (67–100)
|
66.7 (50–75)
|
< 0.001*
|
Cognitive functioning
|
83.3 (66.7-100)
|
83.3 (67–100)
|
66.7 (50–83.3)
|
< 0.001*
|
Social functioning
|
66.7 (33.3-83.3)
|
66.7 (50–83.3)
|
33.3 (33–66.7)
|
< 0.001*
|
Symptom scales
|
25.9 (16-35.8)
|
22.5 (12.7–31.3)
|
34.6 (24.1–41.4)
|
< 0.001*
|
Fatigue
|
33.3 (22.2-55.6)
|
33.3 (11.1–44.4)
|
44.4 (33.3–66.7)
|
< 0.001*
|
Nausea and vomiting
|
0.0 (0-16.7)
|
0.0 (0–16.7)
|
0.0 (0–16.7)
|
0.097
|
Pain
|
33.3 (16.7-66.7)
|
33.0 (16.7–50)
|
50.0 (33.3–66.7)
|
< 0.001*
|
Dyspnoea
|
0.0 (0-33.3)
|
0.0 (0–33.3)
|
33.0 (0–33.3)
|
0.033
|
Insomnia
|
33.3 (33-66.7)
|
33.3 (0–66.7)
|
33.3 (33–66.7)
|
0.319
|
Appetite loss
|
0.0 (0-33.3)
|
0.0 (0–33.3)
|
33.0 (0–33.3)
|
0.096
|
Constipation
|
0.0 (0-33.3)
|
0.0 (0–33.3)
|
33.3 (0–33.3)
|
< 0.001*
|
Diarrhoea
|
0.0 (0-33.3)
|
0.0 (0–33.3)
|
0.0 (0–33.3)
|
0.591
|
Financial difficulties
|
33.3 (0-66.7)
|
33.0 (0–33.3)
|
33.3 (33–66.7)
|
< 0.001*
|
Spiritual interests
|
3.8 (3.5-4.2)
|
4.0 (3.7–4.4)
|
3.6 (3.2–3.9)
|
< 0.001*
|
Related to beliefs
|
3.0 (2.6-3.6)
|
3.0 (2.6–3.6)
|
2.9 (2.4–3.3)
|
0.055
|
Religion, positive attitudes toward life
|
4.0 (3.8-4.8)
|
4.3 (4–5)
|
3.8 (3–4)
|
< 0.001*
|
Love to/from others
|
4.0 (3.8-4.5)
|
4.0 (3.8–4.5)
|
3.8 (3.5–4)
|
0.003*
|
Seeking for the meaning of life
|
4.0 (3.7-4.3)
|
4.0 (4–4.7)
|
4.0 (3–4)
|
0.001*
|
Peaceful mind
|
4.0 (3.7-4.7)
|
4.3 (4–5)
|
4.0 (3.3–4.3)
|
< 0.001*
|
- Chi-square test. Fisher's exact test. Mann–Whitney U test. *p < 0.01
- Continuous data were expressed median and IQR
- Categorical data were expressed number and percentage